We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

78 hedge funds and large institutions have $321M invested in ANACOR PHARMACEUTICALS INC COM in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 8

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

95% more capital invested

Capital invested by funds: $165M → $321M (+$157M)

16% more funds holding

Funds holding: 6778 (+11)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
78
Holders Change
+11
Holders Change %
+16.42%
% of All Funds
2.53%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
31
Reduced
15
Closed
8
Calls
$484K
Puts
Net Calls
+$484K
Net Calls Change
+$505K
Name Holding Trade Value Shares
Change
Change in
Stake
U
26
UBS
Switzerland
$1.45M +$108K +12,373 +10%
MSA
27
Mason Street Advisors
Wisconsin
$1.43M +$1.18M +134,646 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.41M +$55.5K +6,349 +5%
USAA
29
United Services Automobile Association
Texas
$1.25M
T. Rowe Price Associates
30
T. Rowe Price Associates
Maryland
$1.06M -$544K -62,187 -38%
TCIM
31
TIAA CREF Investment Management
New York
$1.06M +$47.5K +5,428 +6%
Ameriprise
32
Ameriprise
Minnesota
$1.03M +$838K +95,799 +5,672%
JGC
33
J. Goldman & Co
New York
$929K +$765K +87,500 New
CCI
34
Columbus Circle Investors
$928K -$3.82M -436,955 -83%
CS
35
Credit Suisse
Switzerland
$921K +$457K +52,226 +151%
TC
36
TFS Capital
Pennsylvania
$884K -$999K -114,239 -58%
WMSA
37
Weiss Multi-Strategy Advisers
New York
$850K +$700K +80,000 New
BIM
38
BlackRock Investment Management
Delaware
$764K +$51.5K +5,888 +9%
DC
39
Deere & Company
Illinois
$576K -$441K -50,393 -48%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$536K +$442K +50,486 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$485K +$13.1K +1,499 +3%
AllianceBernstein
42
AllianceBernstein
Tennessee
$453K +$5.89K +673 +2%
SIP
43
Stoneridge Investment Partners
Pennsylvania
$432K +$356K +40,699 New
HVC
44
Healthcare Value Capital
New Jersey
$401K
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$398K +$7.87K +900 +2%
Charles Schwab
46
Charles Schwab
California
$391K
TA
47
Teachers Advisors
New York
$386K +$26.9K +3,081 +9%
CBOA
48
Commonwealth Bank of Australia
Australia
$349K +$7K +800 +2%
Barclays
49
Barclays
United Kingdom
$332K +$238K +27,206 +447%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$327K

ANAC Hedge Fund Activity: Q3 2013 in Review

78 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2013, worth a combined $321M — up 95% from $165M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ANAC positions and 8 closed out — a net gain of 11 holders — while 31 added to existing stakes and 15 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $6.45M. The largest seller was Columbus Circle Investors, cutting an estimated $3.82M.

  • 78 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2013, up from 67 in Q2 2013.
  • Funds reported $321M of ANACOR PHARMACEUTICALS INC COM stock for Q3 2013, up 95% quarter-over-quarter.
  • 19 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2013 and 8 closed out, a net change of +11 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2013 was Consonance Capital Management, an estimated $6.45M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2013 was Columbus Circle Investors, an estimated $3.82M sold.

Based on aggregated 13F filings for Q3 2013.